Symbols

Symbols

RNTX

RNTX News

Newswire

19:01

Rein Therapeutics shares surge 10.66% after-hours as Voss Capital buys $127K stake and reports positive LTI-03 clinical results.

17:36

Voss Capital LP buys 104183 shares in Rein Therapeutics for $1.22/share on Nov 14.

07:33

Rein Therapeutics Reports Positive LTI-03 Study Results in IPF Patients.

17:42

Rein Therapeutics shares surge 22.39% after-hours as FDA clears Phase 2 IPF trial resumption.

17:07

Rein Therapeutics shares surge 14.18% after-hours as FDA lifts clinical hold on LTI-03 IPF trial, enabling U.S. enrollment resumption.

About RNTX

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction